An Introduction to Mathew Palmer, Accelagen’s Chief Growth & Commercial Officer
Accelagen is thrilled to welcome Mathew Palmer as our new Chief Growth & Commercial Officer (CGCO). With an exceptional track record spanning nearly 30 years in the life sciences industry, Mathew’s experience and leadership will be invaluable as we continue to expand and enhance our services. In this post, we’ll introduce Mathew, highlight his professional […]
Accelagen Partners with Griffith University on Groundbreaking World-First Clinical Trial for Treating Spinal Cord Injuries
In a pioneering collaboration, Accelagen is joining forces with Griffith University to support a world-first Phase I clinical trial that could revolutionise the treatment of spinal cord injuries (SCI). This groundbreaking study, which focuses on a novel cell-based therapy, aims to restore lost functions in patients with severe spinal cord damage and offers hope for […]
Accelagen attending JP Morgan Health Conference in San Francisco
Next month, Accelagen will be attending the highly anticipated Biotech Showcase in association with the JP Morgan Health Conference in San Francisco, marking another pivotal moment in the biotech industry’s calendar. As one of the most important global gatherings for healthcare professionals, industry investors, and innovators, the JP Morgan Health Conference serves as a hub […]
Biometric Support by Accelagen from a Data Management Perspective
In the world of clinical trials and maximizing the key outcomes possible, Data Management and Biostatistics are two critical components that often intersect. From data collection and validation to ensuring compliance with regulatory requirements, the complexity of these services requires a specialised team with both experience and a deep understanding of the technologies and methodologies […]
World-Class Medical Monitoring Offered Worldwide by Accelagen
Accelagen offers world-class medical monitoring services that go beyond just compliance. When it comes to conducting clinical trials, one critical component often stands out as both a necessity and a challenge: Medical Monitoring. While many organisations recognise its importance, not all clinical trial providers offer the depth and dedication of medical monitoring services that are […]
Accelagen Offers a Full Suite of Regulatory Submission Management Services
Accelagen Offers a Full Suite of Regulatory Submission Management Services At Accelagen, our expertise in regulatory submission management is pivotal for our clients in their drug development and marketing journey across the globe. Regulatory submission requirements are exceptionally important and may be invariably complex. A smooth and successful strategy requires an experienced and dedicated team […]
Accelagen Offers Assurance and Convenience by Using Proven CDISC Standards with the Cutting-edge ePRO System
Accelagen proudly employs this system, as we are devoted to providing the best experience available. Using the ePRO platform, Accelagen provide patients with a unique link via their email, which leads to a very secure portal where site staff and patients can simply log in and report their outcomes within a private, secure environment. Additional […]
Accelagen Biggest Takeaway from Bio International in 2024: Interest in the Australian Advantage
Accelagen’s Time at Bio in San Diego: The Many Ongoing Conversations About the Australian Advantage The Accelagen team has just returned home earlier this month from another wonderful time attending the Bio International Conference – this time in sunny San Diego, California. We had the chance to meet with so many friends and colleagues, and […]
Accelagen will be on-hand in San Diego next week for Bio 2024
Accelagen will be on-hand in San Diego next week for Bio 2024 BIO 2024 represents our 3rd attendance at the Bio International Conference, and the 2nd consecutive year after Boston last year. The opportunities that attending the BIO conferences has provided to us have been amazing. We’ve been able to meet and engage with clients, […]
The Value of Strategic Consultation in Regulatory Affairs from Accelagen
Avoiding the Pitfalls that Can Arise During the Regulatory Submissions Process At Accelagen, our Regulatory Affairs team are involved in many parts of the drug development process, including, the management of regulatory applications for companies who are seeking marketing approval in Australia, New Zealand, or other countries. This area is predominantly where Accelagen has its […]